💫🌟🔬 Gleason system evolution: Fundamental for accurate prostate cancer diagnosis and prognosis🌟 Alessia Cimadamore Liang Cheng, MD Antonio Lopez-Beltran Carmine Franzese Gianluca Giannarini Alessandro Crestani Eamonn T. Rogers Rodolfo Montironi 📊 Grade Groups (GGs): Developed from Gleason

The EMA has approved Enfortumab Vedotin and pembrolizumab for 1st line urothelial cancer. It supersedes 1st platinum based therapy as the new standard of care in Europe. astellas.com/en/news/29371?…

I am happy to share that our most recent work on prostate cancer from Vasan Yegnasubramani (co-first author Rulin Wang) was published today in Nature Communications. This was a real team effort, with many folks to thank for their contribution nature.com/articles/s4146…

👏 Congratulations to the Northwestern Feinberg School of Medicine team on this fantastic research! They performed single-cell RNA-sequencing and molecular pathology of the comparative biology between human #ProstateCancer and 🔑key stages in the evolution of a 🧬 genetically engineered mouse model.

🚨Hot off the press👉Pleased to share with the 🌎 our commentary published in Cancer Cell Cell 👉Precision oncology across the ages: Impact on children, adolescents, and young adults 👉#PrecisionOncology Is Age & Tissue-Agnostic #RET #NTRK #BRAF #Precisionmedicine

Journal Officiel du 30/08 ( arrêté du 27/08) : le Darolutamide enfin remboursé en 🇫🇷 dans le traitement du cancer de la prostate sensible à la castration en association avec le docetaxel et une suppression androgenique. Association Française d'Urologie - AFU AFUF Bayer France legifrance.gouv.fr/jorf/id/JORFTE…

Toxicity After Prostate Radiation Therapy: Addressing the Transurethral Resection of the Prostate (TURP) Challenge @RaguRatnakumaran ⁦Vedang Murthy⁩ ⁦Priyamvada Maitre⁩ sciencedirect.com/science/articl…

It takes >3-4 weeks of steroids (@ any dose >5 mg pred/d) to pose risk of adrenal insufficiency – Hence, Endocrine Society Guideline says short-term glucocorticoid therapy of <3-4 wks, irrespective of dose, DOES NOT require GC tapering buff.ly/4gggMq6

So, is there no risk when using 5mg pred/d in association with abiraterone in #prostatecancer ? Some patients do present real adrenal insufficiency when discontinuing treatment after 24mo. Do we need a synacthen test and a pred progressive decrease? Olivier Fogel Marc-Olivier Timsit, MD, PhD 🎗️

🔥A 9-year follow-up from the RADICALS-HD trial showed no significant difference in metastasis-free survival among prostate cancer patients receiving no ADT, 6-month ADT, or 24-month ADT after postoperative radiotherapy. ✅492 patients ✅10 years, 80% (no ADT), 77% (6-month

5-α Reductase Inhibitors and Prostate Cancer Mortality out on JAMA Network Open jamanetwork.com/journals/jaman… Population-based cohort study investigates whether the use of 5-alpha-reductase inhibitors💊(5-ARIs), commonly prescribed for benign prostatic hyperplasia (BPH) and known to

Addition of ARPIs to ADT increases the risk of cardiac disorders( ie., IHD, AF, & hypertension). Each ARPI exhibits a distinct cardiovascular event profile. Selecting patients carefully & vigilant monitoring for cardiovascular issues is imperative. nature.com/articles/s4139…

"Prévenir et guérir les maladies de le prostate" Lundi 16 septembre Mairie du 15 avec les équipes d’urologie, oncologie et radiothérapie de l'Hôpital européen Georges-Pompidou AP-HP AP-HP Institut du Cancer Paris CARPEM Charles Dariane Constance Thibault Marc-Olivier Timsit, MD, PhD 🎗️ Jean-Emmanuel Bibault et les associations ANAMACaP Cerhom

🚴‍♂️ Demain, c'est le jour J ! Merci à tous les participants de "Roulons contre le cancer de la prostate" au Mont Ventoux avec @AFU. 💙 Ensemble, faisons la différence ! Préparez-vous à rouler ! 💪 #Santé #CancerProstate #Prévention #Cyclisme #RoulonsEnsemble #MontVentoux

Parkinson disease begins in the gut. Mucosal damage in the upper GI tract (erosions, esophagitis, ulcers, or peptic injury) have a 76% ⬆️ risk of #Parkinsons. 🧠 #MedTwitter #GITwitter #neurology #neurotwitter #microbiome jamanetwork.com/journals/jaman…

🚨 PUBLICATION ALERT 🚨 Testosterone recovery after androgen deprivation therapy Authors included: Eric Li, MD, Chalairat, MD, MPH, Sai Kaushik Shankar Ramesh Kumar, MS, Clayton Neill, BS, Yutai Li, MA, Edward Schaeffer, MD, PhD, MD, PhD, Hiten Patel, MD, MPH, Ashley Ross MD PhD

donating a kidney is safer than it's ever been -- mortality from donor nephrectomy now one-third of what it was a decade ago, less than 1 in 10,000 -- spread the word! jamanetwork.com/journals/jama/…

Les coureurs s'élancent pour l'ascension du mont Ventoux, avec en tête de peloton, 4 cyclistes handisports ! 🚴‍♂️ Derrière eux : des urologues, des patients et anciens patients, des membres d'association, des familles de patients, des cyclistes passionnés. 💪 Courage et bonne

🧬 Exciting new study shows how Prolaris genomic testing can help men with intermediate-risk #ProstateCancer make better treatment decisions! 📊 Patients recommended for Active Surveillance (AS) by Prolaris were 2x more likely to choose AS and 1.5x more likely to stay on it for 3

Just in The Lancet Oncology 👉Zr-girentuximab PET–CT is highly accurate for detecting ccRCC #kidneycancer (like PSMA-PET in prostate ca) Congrats, Brian Brian Shuch, MD et al, on these practice-impacting data. Open access👉tinyurl.com/4cwkm8u5 Michael Morris OncoAlert UroToday.com